HER2 expression | |||||
Variable | Total (n) | Absent | Present | χ2 | P |
Sex (n) | 0.245 | 0.620 | |||
Male | 30 | 23 | 7 | ||
Female | 15 | 13 | 2 | ||
Age (y) | 0.405 | 0.524 | |||
<60 | 24 | 19 | 5 | ||
≥60 | 21 | 17 | 4 | ||
Tumor size (cm) | 0.047 | 0.828 | |||
<5 | 19 | 15 | 4 | ||
≥5 | 26 | 21 | 5 | ||
Lymph node metastasis | 0.058 | 0.810 | |||
Negative | 18 | 15 | 3 | ||
Positive | 27 | 21 | 6 | ||
Histologic type | 7.741 | 0.005 | |||
Well- or moderately differentiated adenocarcinoma | 21 | 13 | 8 | ||
Poorly differentiated adenocarcinoma | 24 | 23 | 1 | ||
T category | 0.040 | 0.841 | |||
T1/T2 | 14 | 12 | 2 | ||
T3/T4 | 31 | 24 | 7 | ||
Location | |||||
Proximal | 7 | 5 | 2 | 0.381 | 0.537 |
Distal | 38 | 31 | 7 | ||
Mean SUVmax | 8.619 ± 5.878 | 3.789 ± 2.613 | 0.021 |